OTCMKTS:BIOQ Bioqual (BIOQ) Stock Price, News & Analysis $32.50 0.00 (0.00%) As of 07/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsBuy This Stock About Bioqual Stock (OTCMKTS:BIOQ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bioqual alerts:Sign Up Key Stats Today's Range$32.50▼$32.5050-Day Range$32.50▼$37.5152-Week Range$32.50▼$43.55VolumeN/AAverage Volume68 shsMarket Capitalization$28.93 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bioqual, Inc. is a U.S.-based contract research organization specializing in preclinical immunology and pharmacology services for the biopharmaceutical industry. The company offers a range of in vivo and in vitro testing solutions designed to support vaccine development, immuno-oncology programs and other therapeutic modalities. Bioqual’s service portfolio encompasses assay development, safety and efficacy studies, biomarker analysis and specialized immunogenicity assessments. Leveraging proprietary humanized animal models and nonhuman primate research platforms, Bioqual helps clients evaluate biological activity, toxicity and pharmacokinetics of investigational compounds. The company’s facilities include vivarium capabilities, tissue culture laboratories and bioanalytical suites configured to meet regulatory standards. Bioqual’s scientific team collaborates with pharmaceutical and biotechnology companies to design study protocols, collect and analyze data, and prepare comprehensive study reports for regulatory submissions. Headquartered in Maryland with additional facilities in California, Bioqual serves a global client base ranging from emerging biotech firms to large pharmaceutical corporations. Its geographically distributed laboratories enable scalable study execution and logistical flexibility. While detailed leadership information is not broadly disclosed, Bioqual’s management is led by seasoned professionals with extensive experience in preclinical development and immunology research.AI Generated. May Contain Errors. Read More Receive BIOQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOQ Stock News HeadlinesBIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2026April 21, 2026 | businesswire.comBIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2026January 22, 2026 | businesswire.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. | Altimetry (Ad)PETA files complaint over Mississippi monkey truck crash, citing animal welfare violationsNovember 7, 2025 | msn.comBIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2026October 21, 2025 | businesswire.comBIOQUAL Presents Financial Results for Fiscal Year 2025September 19, 2025 | businesswire.comBioqual, Inc. (BIOQ) stock price, news, quote & history - Yahoo FinanceJuly 10, 2025 | nz.finance.yahoo.comBIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the companyApril 30, 2025 | businesswire.comSee More Headlines BIOQ Stock Analysis - Frequently Asked Questions How have BIOQ shares performed this year? Bioqual's stock was trading at $38.51 at the start of the year. Since then, BIOQ shares have decreased by 15.6% and is now trading at $32.50. How were Bioqual's earnings last quarter? Bioqual Inc. (OTCMKTS:BIOQ) issued its earnings results on Tuesday, April, 21st. The company reported ($0.84) earnings per share (EPS) for the quarter. The firm had revenue of $9.84 million for the quarter. Bioqual had a negative trailing twelve-month return on equity of 2.69% and a negative net margin of 2.27%. How do I buy shares of Bioqual? Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bioqual own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bioqual investors own include Align Technology (ALGN), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Global X Cloud Computing ETF (CLOU). Company Calendar Last Earnings4/21/2026Today7/06/2026Fiscal Year End5/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryBusiness Services Current SymbolOTCMKTS:BIOQ CIK719711 Webwww.bioqual.com Phone(240) 404-7654FaxN/AEmployees114Year Founded1981Profitability EPS (Trailing Twelve Months)($1.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.05 million Net Margins-2.27% Pretax Margin-3.65% Return on Equity-2.69% Return on Assets-1.50% Debt Debt-to-Equity RatioN/A Current Ratio4.01 Quick Ratio4.01 Sales & Book Value Annual Sales$48.87 million Price / Sales0.59 Cash Flow$1.48 per share Price / Cash Flow21.99 Book Value$40.42 per share Price / Book0.80Miscellaneous Outstanding Shares890,000Free Float543,000Market Cap$28.93 million OptionableNot Optionable Beta-0.21 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:BIOQ) was last updated on 7/7/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioqual Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioqual With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
